Artificial Organs Market Size 2024-2028

The global artificial organs market size is estimated to grow by USD 14.85 billion at a CAGR of 9.49% between 2023 and 2028. Market growth is fueled by various factors, including increased exploration and production activities, the economic benefits of pipeline transportation, and escalating global energy demand. These drivers are pivotal in taking the industry forward. However, challenges persist, such as the exorbitant cost of artificial organs, along with the complexities and limitations associated with their usage. Furthermore, insufficient reimbursement policies and denials from private insurance companies pose significant hurdles. Overcoming these challenges is crucial for sustaining market momentum and ensuring equitable access to innovative medical solutions. Addressing cost concerns, enhancing artificial organ functionalities, and advocating for comprehensive reimbursement policies are essential steps toward fostering growth and advancing healthcare technologies. Despite these obstacles, the industry remains resilient, driven by ongoing innovation and the pressing need to meet evolving healthcare demands globally.

What will be the Size of the Market During the Forecast Period?

To learn more about this report, Request Free Sample

Key Companies & Market Insights

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about key companies, including:

Abbott Laboratories, Asahi Kasei Corp., B.Braun SE, Baxter International Inc., BioTelemetry Inc., BIOTRONIK SE and Co. KG, BiVACOR Inc., Boston Scientific Corp., Cochlear Ltd., F. Hoffmann La Roche Ltd., Fresenius Medical Care AG and Co. KGaA, Insulet Corp., MED EL Elektromedizinische Gerate GmbH, Medtronic Plc, Nihon Kohden Corp., Nikkiso Co. Ltd., Nipro Corp., Sonova AG, SynCardia Systems LLC, and Tandem Diabetes Care Inc.

Abbott Laboratories - The company offers artificial organs that include a gut microbiome, which is comprised of an ecosystem of microbes like bacteria, fungi, and viruses that naturally live both on and within the US, protecting the US against harmful germs and helping break down our food to release energy.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Market Segmentation 

By Usage

The market share growth of the implantable segment will be significant during the forecast period. The implantable segment is experiencing significant growth due to the high prevalence of organ failures caused by conditions such as hypertension, diabetes, and road accidents. With approximately 735,000 Americans experiencing a heart attack each year, the need for organ transplants and artificial alternatives is increasingly urgent. Live donor programs and advancements in technology, such as silicon, plastics, steel, and permanent and temporary ones are driving innovation in this field. 

Get a glance at the market contribution of various segments Download PDF Sample

The implantable segment was valued at USD 11.85 billion in 2018. Notable developments include the world's smallest pacemaker, the Micra AV, approved by the FDA in January 2020. End-stage renal disease, kidney failure, and dialysis are major areas of focus, with Medicare and transplant recipients driving demand. Artificial intelligence, 3D bioprinting, and electronic bionics are also playing a role in advancing this industry. However, challenges such as transplant side effects, skin irritation, and procedure costs remain. The geriatric population and diabetes medicines are also significant factors influencing the market.

Regional Analysis

For more insights about the market share of various regions Download PDF Sample

North America is estimated to contribute 46% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers will shape the market during the forecast period.

The Market in North America is projected to expand at a notable rate due to the rising prevalence of chronic diseases such as diabetes, cardiovascular diseases, and CKD. The US and Canada dominate the market, fueled by advanced devices, numerous product launches, and market leaders. Artificial livers, pancreas, lungs, kidneys, and other organs are in high demand to address conditions like cancer, stroke, heart disease, and respiratory diseases. Organ rejection and transplantation necessitate renal replacement and transplant surgeries, which involve vascularization and the use of blood vessels to transport oxygen, nutrients, and cell-secreted waste. Biomaterials and processing technologies, including decellularization, organ donation, and retrieval, contribute to the development of kidney substitutes, hemodialysis, cardiopulmonary bypass (CPB), apheresis therapy, peritoneal dialysis, lung substitutes, plasma separation, and bioreactors. Type 1 diabetes patients benefit from continuous glucose monitors and cochlea implants.

Buy Full Report Now

Market Dynamics and Customer Landscape

The market encompasses the production and distribution of various types of artificial organs, including kidneys, livers, pancreas, and artificial hearts. These organs are designed to replace failed organs due to organ failures caused by end-stage kidney disease, road accidents, or heart disease, among other reasons. Live donor programs and organ donors provide the necessary human organs for transplant surgeries, while temporary ones such as artificial kidneys and dialysis machines offer renal replacement therapy for patients awaiting a donor organ. Permanent artificial organs, made from materials like silicon, plastics, and steel, are under development for long-term use. Apheresis therapy and advanced technologies like artificial intelligence are also playing a significant role in the development and implementation of these organs. The market for artificial organs is continually evolving, with a focus on improving vascularization, ensuring proper oxygen and nutrient supply, and minimizing organ rejection. Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

Key Market Driver

The increasing prevalence of chronic disorders is one of the key factors driving the growth of the market. The rising incidence of organ failures due to conditions such as kidney disease, diabetes, hypertension, and cardiovascular diseases (CVDs) is driving the demand. According to the CDC, approximately 795,000 Americans experience a stroke annually. Organ failures can result from various causes, including road accidents, end-stage renal disease, and diabetes complications leading to amputations and limb loss. Kidney transplants, artificial hearts, lungs, kidneys, pancreas, and livers, are made from materials like silicon, plastics, and steel. Transplants, whether from live donors or deceased donors, come with side effects such as skin irritation and procedure costs.

Moreover, the geriatric population, with its higher prevalence of organ failures, is a significant market. Advancements in technology, such as artificial intelligence, 3D bioprinting, and electronic bionics, are improving functionality and reducing the side effects of these temporary and permanent ones. Medicare and transplant recipients are major consumers of these organs. Diabetes medicines and CVD treatments are also contributing factors to the increasing demand. Thus, the increase in the prevalence of chronic diseases is the major factor that is expected to drive the growth of the market during the forecast period.

Significant Market Trends

The emergence of TAH is the primary trend in the market. The market has gained significant attention due to the increasing number of organ failures, particularly in end-stage heart and kidney disease patients awaiting transplants. The scarcity of available organs for transplantation, driven by the rising incidence of cardiovascular diseases and road accidents, has led to an increased reliance on mechanical circulatory support devices such as total artificial hearts (TAH). Vendors like SynCardia offer pneumatically driven TAH with pulsatile systems capable of handling high flows.

Additionally, they include kidney implants, artificial hearts, artificial lungs, cochlear implants, artificial kidneys, artificial pancreas, and artificial livers. These organs are made from materials like silicon, plastics, and steel, and can be permanent or temporary. Organ failures, including kidney failure due to end-stage renal disease, diabetes, and hypertension, can lead to dialysis and renal failure. The geriatric population is particularly vulnerable to organ failures and transplant side effects such as skin irritation and procedure costs. Advancements in technology include artificial intelligence, 3D bioprinting, and electronic bionics, aiming to improve organ transplant procedures and reduce the need for diabetes medicines. This will have a significant impact on the growth of the market during the forecast period.

Major Market Challenge

The complications and limitations are a major challenge for market growth. The market has seen significant growth due to the increasing number of organ failures caused by various health conditions, such as kidney failure due to end-stage renal disease, diabetes, and hypertension, as well as organ damage resulting from road accidents and amputations. While live donor programs and transplants offer a solution, the high cost of these procedures and the need for continuing medical surveillance make an attractive alternative. These organs, including artificial hearts, lungs, kidneys, pancreas, and livers, are constructed using a combination of silicon, plastics, and steel, and involve the use of biomaterials, clogs, and low-viscosity additives.

Additionally, the costs associated with these permanent and temporary ones can range from USD 17,500 to USD 120,000 a year, including procedure costs, Medicare, and transplant side effects like skin irritation. With advancements in technology, such as artificial intelligence and 3D bioprinting, the future holds promise for reducing costs and improving outcomes for transplant recipients in the geriatric population. Additionally, electronic bionics and diabetes medicines play a crucial role in supporting the functioning of these organs. However, these factors will hinder the market growth during the forecast period.

You may also be interested in:

Artificial Organs and Bionic Implants Market in Spain - Artificial Organs and Bionic Implants Market in Spain by Product and End-user - Forecast and Analysis 
3D Bioprinting Market - 3D Bioprinting Market by Application, Solution, and Geography - Forecast and Analysis
Metal Implants and Medical Alloys Market - Metal Implants and Medical Alloys Market Analysis North America, APAC, Europe, Middle East and Africa, South America - US, China, Japan, France, UK - Size and Forecast

Market Customer Landscape

The market forecast report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on market growth and forecasting, adoption rates in different regions based on penetration. Furthermore, the market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market forecasting and market growth analysis strategies.

 Customer Landscape

Segment Overview

The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD Billion " for the period 2024-2028, as well as historical data from 2018 - 2022 for the following segments.

• Usage Outlook
  • Implantable
  • Extracorporeal
• Product Outlook 
  • Artificial heart
  • Artificial kidney
  • Cochlear implants
  • Artificial pancreas
• Region Outlook 
  • North America
    • The U.S.
    • Canada
  • Europe
    • The U.K.
    • Germany
    • France
    • Rest of Europe
  • Asia
    • China
    • India
  • Rest of World (ROW)
    • Brazil
    • Argentina
    • Rest of the Middle East & Africa

Market Analyst Overview

The market is a significant segment of the healthcare industry, focusing on the production and distribution of artificial transplants for various organs. Organ transplants, including kidney transplants, have seen significant progress over the years. These advances are largely due to the efforts of various programs dedicated to increasing the number of organ donors. The growth in organ transplant procedures, particularly lung transplants and liver transplants, has been facilitated by artificial organs and the constant evolution in the field of organ transplant technology. One major challenge in organ transplants is organ failure. The high demand for organs, coupled with a limited supply, has made artificial organs a critical area of research. Artificial organs, including artificial hearts and artificial kidneys, offer a lifeline to patients suffering from end-stage organ failure. Procedures such as dialyses, using artificial organs, have become essential for patients awaiting organ transplants. Organ transplant centers play a pivotal role in connecting donors with recipients. These centers operate within a broader organ transplant network, which helps streamline the process of organ transplants. Organizations dedicated to organ transplants, such as the Organ Transplant Foundation, work tirelessly to support patients through all stages of the transplant journey. Their focus on end-stage organ failure and the need for more organ donors has led to significant growth in the organ transplant market.

The impact of organ transplant research is evident in the improved success rates for organ transplant procedures. As technology evolves, organ transplant recipients are experiencing better outcomes and longer lifespans. Moreover, organ transplant technology is advancing at a rapid pace, making it possible to create more efficient ones and improve overall transplant success rates. However, this progress comes with the need for strict organ transplant regulations. These regulations ensure that organ transplants are conducted ethically and safely. Furthermore, organ transplant reimbursement policies play a crucial role in ensuring that patients have access to the necessary financial resources for their treatments. This, in turn, influences the overall growth of the organ transplant market. With the continued efforts of organ transplant organizations, ongoing research, and advancements, the future looks promising for organ transplant trends. The collaboration among organ transplant centers, the organ transplant network, and other key stakeholders will continue to drive growth and innovation in this field, ensuring that more lives are saved through organ transplants.

This market is driven by the increasing number of End-stage Organ Transplant Patients and advancements in Artificial Organs Technology. Organs Transplant Recipients are growing due to the rising prevalence of Chronic Kidney Disease, Liver Diseases, and Lung Diseases. The Organs Transplant Market is expected to grow significantly due to the increasing number of Organ Donors and advancements in Organ Transplant Procedures. Moreover, the Organs Transplant Market is witnessing the implementation of stringent Organs Transplant Regulations and Reimbursement Policies, which is expected to boost the market growth. The Organs Transplant Market is also witnessing the emergence of new players and collaborations between established players, leading to the development of innovative Organs Transplant Solutions.

Download Sample PDF at your Fingertips

What are the Key Data Covered in this Market Research and Growth Report?

• CAGR of the market during the forecast period
• Detailed information on factors that will drive the growth of the between 2024 and 2028
• Precise estimation of the size of the market and its contribution in focus to the parent market
• Detailed analysis of customer landscape covering diver of price sensitivity, adoption of the lifecycle, and key purchase criteria 
• Companies landscape comparing criticality of inputs and factors of differentiation
• Exclusive Matrix on companies position and classification
• Accurate predictions about upcoming trends and changes in consumer behavior
• Growth of the market across North America, Europe, Asia, and Rest of World (ROW)
• Thorough analysis of the market’s competitive landscape and detailed information about companies
• Comprehensive analysis of factors that will challenge the growth of companies